New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Cholangiocarcinoma and gallbladder cancer
Left versus right in colon cancer
The GI oncologist of the future
Minimally invasive surgery for cancer of the oesophagus
WIN 2017 conference review
The challenge of approving add-on therapies for patients with metastatic cancer
Molecular medicine in lung cancer
Current and future immune approaches in precision medicine
Precision medicine enabled histology agnostic development of immunotherapeutics
Incorporating liquid biopsies into clinical trials